Malle, L. Et Al. 2017. Stimulator of Interferon Genes (STING)-Induced Endothelial-Mesenchymal Transition (EndMT) Contributes to Interstitial Lung Disease in StingAssociated Vasculopathy with Onset in Infancy (SAVI) Patients. ARTHRITIS & RHEUMATOLOGY , vol.69 .

Malle, L., Yang, D., de Jesus, A. A., Chen, G., Marrero, B., Sanchez, G. A. M., ... Liu, Y.(2017). Stimulator of Interferon Genes (STING)-Induced Endothelial-Mesenchymal Transition (EndMT) Contributes to Interstitial Lung Disease in StingAssociated Vasculopathy with Onset in Infancy (SAVI) Patients. ARTHRITIS & RHEUMATOLOGY , vol.69.

Malle, Louise Et Al. "Stimulator of Interferon Genes (STING)-Induced Endothelial-Mesenchymal Transition (EndMT) Contributes to Interstitial Lung Disease in StingAssociated Vasculopathy with Onset in Infancy (SAVI) Patients," ARTHRITIS & RHEUMATOLOGY , vol.69, 2017

Malle, Louise Et Al. "Stimulator of Interferon Genes (STING)-Induced Endothelial-Mesenchymal Transition (EndMT) Contributes to Interstitial Lung Disease in StingAssociated Vasculopathy with Onset in Infancy (SAVI) Patients." ARTHRITIS & RHEUMATOLOGY , vol.69, 2017

Malle, L. Et Al. (2017) . "Stimulator of Interferon Genes (STING)-Induced Endothelial-Mesenchymal Transition (EndMT) Contributes to Interstitial Lung Disease in StingAssociated Vasculopathy with Onset in Infancy (SAVI) Patients." ARTHRITIS & RHEUMATOLOGY , vol.69.

@article{article, author={Louise Malle Et Al. }, title={Stimulator of Interferon Genes (STING)-Induced Endothelial-Mesenchymal Transition (EndMT) Contributes to Interstitial Lung Disease in StingAssociated Vasculopathy with Onset in Infancy (SAVI) Patients}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2017}